日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Real-World Safety and Early Effectiveness of First-Line Enfortumab Vedotin Plus Pembrolizumab with Routine Dexamethasone Premedication in Advanced Urothelial Carcinoma

一线恩福妥单抗联合帕博利珠单抗治疗晚期尿路上皮癌，常规地塞米松预处理的真实世界安全性和早期疗效

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers18050739
Hara, Takuto; Wakita, Naoto; Tobe, Taisuke; Ueki, Hideto; Okamura, Yasuyoshi; Bando, Yukari; Suzuki, Kotaro; Terakawa, Tomoaki; Hyodo, Yoji; Yao, Akihisa; Chiba, Koji; Teishima, Jun; Miyake, Hideaki
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Correction to: Policy recommendations for promoting nuclear medicine therapy in Japan 2025, from the Working Group for promoting nuclear medicine therapy of the Japan Society of Clinical Oncology

更正：日本临床肿瘤学会核医学治疗促进工作组提出的《2025年日本核医学治疗促进政策建议》

期刊:International Journal of Clinical Oncology
影响因子:2.8
doi:10.1007/s10147-025-02925-9
Suzuki, Kotaro; Miyake, Hideaki; Inaki, Anri; Takano, Shoko; Kuboki, Yasutoshi; Mizowaki, Takashi; Nakamura, Katsumasa; Ueno, Makoto; Matsumoto, Shigemi; Obinata, Daisuke; Nakagawa, Tohru; Murakami, Masato; Majima, Yoshiyuki; Yokono, Megumu; Namba, Masao; Yoshino, Takayuki
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Post Hoc Subgroup Analysis of Clinical Outcomes in Patients With High-Risk Metastatic Hormone-Naïve Prostate Cancer: Results From a 3-Year Interim Analysis of the J-ROCK Study

对高危转移性激素敏感性前列腺癌患者临床结局的事后亚组分析：J-ROCK 研究 3 年中期分析结果

期刊:Prostate
影响因子:2.5
doi:10.1002/pros.70118
Mizokami, Atsushi; Matsumoto, Rikiya; Miyake, Hideaki; Uemura, Hiroji; Uemura, Hirotsugu; Kawakami, Satoru; Nakamura, Kazuyoshi; Shigekatsu Maekawa; Tsuchiya, Hiroaki; Okazaki, Sachie; Adachi, Eri; Yano, Ryo; Tajima, Yohei; Fujimoto, Kiyohide; Matsuyama, Hideyasu
肿瘤
肿瘤免疫
ROCK
前列腺癌
免疫/内分泌
发表日期：2026
文献求助 收藏

Kidney transplantation after chronic active Epstein-Barr virus infection remission

慢性活动性EB病毒感染缓解后进行肾移植

期刊:CEN Case Reports
影响因子:0.7
doi:10.1007/s13730-025-01084-0
Tashiro, Yuki; Hyodo, Yoji; Kitamura, Satoshi; Endo, Takahito; Nishioka, Shun; Yokoyama, Naoki; Suzuki, Kotaro; Hara, Takuto; Chiba, Koji; Miyake, Hideaki
炎症/感染
微生物学
发表日期：2026
文献求助 收藏

Robot-assisted nephroureterectomy for urothelial carcinoma in a horseshoe kidney: efficacy of isthmectomy using indocyanine green fluorescence imaging

机器人辅助肾输尿管切除术治疗马蹄肾尿路上皮癌：吲哚菁绿荧光成像评估峡部切除术的疗效

期刊:International Cancer Conference Journal
影响因子:0.5
doi:10.1007/s13691-026-00850-w
Satake, Shun; Hara, Takuto; Wakita, Naoto; Suzuki, Kotaro; Terakawa, Tomoaki; Chiba, Koji; Miyake, Hideaki
肿瘤
IF
肿瘤免疫
发表日期：2026
文献求助 收藏

Efficient differentiation of human iPSCs into Leydig-like cells capable of long-term stable secretion of testosterone.

将人类 iPSCs 高效分化为能够长期稳定分泌睾酮的 Leydig 样细胞

期刊:Stem Cell Reports
影响因子:5.1
doi:10.1016/j.stemcr.2024.102392
Sato Katsuya, Koyanagi-Aoi Michiyo, Uehara Keiichiro, Yamashita Yosuke, Shinohara Masakazu, Lee Suji, Reinhardt Anika, Woltjen Knut, Chiba Koji, Miyake Hideaki, Fujisawa Masato, Aoi Takashi
细胞生物学
Human
发表日期：2025
文献求助 收藏

A conditionally replicative adenovirus vector containing the synNotch receptor gene for the treatment of muscle-invasive bladder cancer

一种含有synNotch受体基因的条件复制型腺病毒载体，用于治疗肌层浸润性膀胱癌

期刊:Cancer Gene Therapy
影响因子:5
doi:10.1038/s41417-025-00879-8
A, Ruhan; Ueki, Hideto; Nishioka, Shunya; Yamazaki, Rion; Maekawa, Marina; Kitagawa, Koichi; Miyake, Hideaki; Shirakawa, Toshiro
肿瘤
肿瘤免疫
Notch
信号转导
微生物学
膀胱癌
发表日期：2025
文献求助 收藏

Primary resistance to nivolumab plus ipilimumab therapy affects second-line treatment outcomes in patients with metastatic renal cell carcinoma

对纳武利尤单抗联合伊匹木单抗治疗的原发性耐药会影响转移性肾细胞癌患者的二线治疗结果。

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.16326
Mori, Kanami; Numakura, Kazuyuki; Matsushita, Yuto; Kojima, Takahiro; Osawa, Takahiro; Sazuka, Tomokazu; Hatakeyama, Shingo; Goto, Keisuke; Yamana, Kazutoshi; Kandori, Shuya; Kimura, Takahiro; Nishiyama, Naotaka; Bando, Yukari; Fujita, Kazutoshi; Ueda, Kosuke; Tanaka, Hajime; Tomida, Ryotaro; Kurahashi, Toshifumi; Kitamura, Hiroshi; Miyake, Hideaki; Habuchi, Tomonori
肿瘤
肾癌
肿瘤免疫
细胞生物学
发表日期：2025
文献求助 收藏

GWAS Identifies SNPs Associated With Severe Adverse Events and Efficacy in Advanced Renal Cell Carcinoma Treated With Nivolumab

全基因组关联研究（GWAS）鉴定出与接受纳武利尤单抗治疗的晚期肾细胞癌患者严重不良事件和疗效相关的单核苷酸多态性（SNP）。

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.70204
Tanegashima, Tokiyoshi; Shiota, Masaki; Akamatsu, Shusuke; Miyake, Hideaki; Takahashi, Masayuki; Oya, Mototsugu; Tsuchiya, Norihiko; Masumori, Naoya; Matsuyama, Hideyasu; Obara, Wataru; Shinohara, Nobuo; Fujimoto, Kiyohide; Nozawa, Masahiro; Ohba, Kojiro; Ohyama, Chikara; Hashine, Katsuyoshi; Kamba, Tomomi; Mita, Koji; Gotoh, Momokazu; Tatarano, Shuichi; Fujisawa, Masato; Tomita, Yoshihiko; Mukai, Shoichiro; Ito, Keiichi; Tokunaga, Shoji; Eto, Masatoshi
肿瘤
肾癌
肿瘤免疫
细胞生物学
发表日期：2025
文献求助 收藏

Safety and efficacy of oral cancer vaccine B440 in patients with PD-1/PD-L1 inhibitor-resistant advanced urothelial cancer: a study protocol for a phase 1 multicenter, open-label, single-arm clinical trial

口服癌症疫苗B440治疗PD-1/PD-L1抑制剂耐药的晚期尿路上皮癌患者的安全性和有效性：一项I期多中心、开放标签、单臂临床试验的研究方案

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-13514-4
Furukawa, Junya; Kakei, Yasumasa; Murakami, Sae; Kita, Hiroshi; Ueki, Hideto; Hara, Takuto; Teishima, Jun; Hinata, Nobuyuki; Miyake, Hideaki; Fujisawa, Masato; Shirakawa, Toshiro
PD-L1
肿瘤
肿瘤免疫
PD-1
发表日期：2025
文献求助 收藏